Smith Group Asset Management »

Corcept Therapeutics Incorporated shares owned by Smith Group Asset Management

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Smith Group Asset Management from 13F filings

Historical chart of Smith Group Asset Management investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Smith Group Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Smith Group Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $393k 12k 32.48
2021-09-30 $540k 27k 19.69

More positions owned by Smith Group Asset Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Meta Platforms Cl A (META)
Cadence Design Systems (CDNS)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Medpace Hldgs (MEDP)
CBOE Holdings (CBOE)
McKesson Corporation (MCK)
NVIDIA Corporation (NVDA)
Electronic Arts (EA)
Veeva Sys Cl A Com (VEEV)
JPMorgan Chase & Co. (JPM)
Pinterest Cl A (PINS)
Kla Corp Com New (KLAC)

View all positions for Smith Group Asset Management

Top funds holding Corcept Therapeutics Incorporated

Vanguard Group
Ingalls & Snyder
Parallel Advisors
Dimensional Fund Advisors
Norden Group
Btim
Federated Investors
D. E. Shaw & Co
Arrowstreet Capital, Limited Partnership
Charles Schwab Investment Management
Man Group
Norges Bank Investment Management
Bank of New York Mellon
Millennium Management
Kynam Capital Management

View all funds holding Corcept Therapeutics Incorporated